Oberweis Asset Management »

Eton Pharmaceuticals shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 192k 21.73

More positions owned by Oberweis Asset Management

Credo Technology Group Holding (CRDO)
Lumentum Hldgs (LITE)
Rambus (RMBS)
Ambarella (AMBA)
Sharkninja (SN)
Applied Optoelectronics (AAOI)
Encompass Health Corp (EHC)
Frontdoor (FTDR)
Adma Biologics (ADMA)
American Superconductor (AMSC)
Sportradar Group Ag Class A Ord (SRAD)
NOVA MEASURING Instruments L (NVMI)
Itron (ITRI)
SkyWest (SKYW)
Sitime Corp (SITM)

View all positions for Oberweis Asset Management

Top funds holding Eton Pharmaceuticals

Opaleye Management
EcoR1 Capital
BlackRock
Vanguard Group
Nantahala Capital Management
Geode Capital Management
Morgan Stanley
Royal Bank of Canada
Westside Investment Management
Cannell Capital
State Street Corporation
Thompson, Siegel, & Walmsley
Jpmorgan Chase & Co
Renaissance Technologies
Divisadero Street Capital Management

View all funds holding Eton Pharmaceuticals